0

Hypertension Collection
 101-120 of 657 Articles
Quality Indicators for Assessing Care of Vulnerable Elders |  16 October 2001
Quality Indicators for Appropriate Medication Use in Vulnerable Elders
Eric L. Knight, MD, MPH; Jerry Avorn, MD
Ann Intern Med. 2001;135(8_Part_2):703-710. doi:10.7326/0003-4819-135-8_Part_2-200110161-00009
Articles |  18 September 2001
Diagnostic Tests for Renal Artery Stenosis in Patients Suspected of Having Renovascular Hypertension: A Meta-Analysis
G. Boudewijn C. Vasbinder, MD; Patricia J. Nelemans, MD, PhD; Alfons G.H. Kessels, MD, MSc; et al.
Ann Intern Med. 2001;135(6):401-411. doi:10.7326/0003-4819-135-6-200109180-00009
Academia and the Profession |  4 September 2001
Perceptions about Complementary Therapies Relative to Conventional Therapies among Adults Who Use Both: Results from a National Survey
David M. Eisenberg, MD; Ronald C. Kessler, PhD; Maria I. Van Rompay, BA; et al.
Ann Intern Med. 2001;135(5):344-351. doi:10.7326/0003-4819-135-5-200109040-00011
Articles |  21 August 2001
Hormone Replacement Therapy and Longitudinal Changes in Blood Pressure in Postmenopausal Women
Angelo Scuteri, MD, PhD; Angelo J.G. Bos, MD, PhD; Larry J. Brant, PhD; et al.
Ann Intern Med. 2001;135(4):229-238. doi:10.7326/0003-4819-135-4-200108210-00007
Brief Communications |  21 August 2001
Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery
Anna M. Sawka, MD; William F. Young, MD; Geoffrey B. Thompson, MD; et al.
Ann Intern Med. 2001;135(4):258-261. doi:10.7326/0003-4819-135-4-200108210-00010
Articles |  17 July 2001
Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease: A Meta-Analysis of Patient-Level Data
Tazeen H. Jafar, MD, MPH; Christopher H. Schmid, PhD; Marcia Landa, MA; et al.
Ann Intern Med. 2001;135(2):73-87. doi:10.7326/0003-4819-135-2-200107170-00007
Editorials |  17 July 2001
The Effect of Angiotensin-Converting Enzyme Inhibitors on the Progression of Nondiabetic Renal Disease: A Pooled Analysis of Individual-Patient Data from 11 Randomized, Controlled Trials
Robert W. Schrier, MD; Raymond O. Estacio, MD
Ann Intern Med. 2001;135(2):138-139. doi:10.7326/0003-4819-135-2-200107170-00015
Articles |  5 June 2001
Home Monitoring Service Improves Mean Arterial Pressure in Patients with Essential Hypertension: A Randomized, Controlled Trial
Mary A.M. Rogers, PhD, MS; David Small, MD; Debra A. Buchan, MD; et al.
Ann Intern Med. 2001;134(11):1024-1032. doi:10.7326/0003-4819-134-11-200106050-00008
Articles |  17 April 2001
Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial
Johannes F.E. Mann, MD; Hertzel C. Gerstein, MD; Janice Pogue, MSc; et al.
Ann Intern Med. 2001;134(8):629-636. doi:10.7326/0003-4819-134-8-200104170-00007
Articles |  6 March 2001
Should All Patients with Type 1 Diabetes Mellitus and Microalbuminuria Receive Angiotensin-Converting Enzyme Inhibitors?: A Meta-Analysis of Individual Patient Data
The ACE Inhibitors in Diabetic Nephropathy Trialist Group*
Ann Intern Med. 2001;134(5):370-379. doi:10.7326/0003-4819-134-5-200103060-00009
Articles |  2 January 2001
Long-Term Weight Loss and Changes in Blood Pressure: Results of the Trials of Hypertension Prevention, Phase II
Victor J. Stevens, PhD; Eva Obarzanek, PhD; Nancy R. Cook, ScD; et al.
Ann Intern Med. 2001;134(1):1-11. doi:10.7326/0003-4819-134-1-200101020-00007
Editorials |  2 January 2001
Obesity and Hypertension: What Should We Do?
Thomas G. Pickering, MD, DPhil
Ann Intern Med. 2001;134(1):72-74. doi:10.7326/0003-4819-134-1-200101020-00016
Brief Communications |  17 October 2000
Long-Term Outcomes of Scleroderma Renal Crisis
Virginia D. Steen, MD; Thomas A. Medsger, MD
Ann Intern Med. 2000;133(8):600-603. doi:10.7326/0003-4819-133-8-200010170-00010
Articles |  21 March 2000
Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease: A Randomized, Controlled Trial
David B. Badesch, MD; Victor F. Tapson, MD; Michael D. McGoon, MD; et al.
Ann Intern Med. 2000;132(6):425-434. doi:10.7326/0003-4819-132-6-200003210-00002
Editorials |  21 March 2000
Epoprostenol (Prostacyclin) and Pulmonary Hypertension
Alfred P. Fishman, MD
Ann Intern Med. 2000;132(6):500-502. doi:10.7326/0003-4819-132-6-200003210-00013
Ideas and Opinions |  1 February 2000
The Diastolic Blood Pressure in Systolic Hypertension
Harold Smulyan, MD; Michel E. Safar, MD
Ann Intern Med. 2000;132(3):233-237. doi:10.7326/0003-4819-132-3-200002010-00010
Currents |  16 November 1999
Computational Genomics: The Medicine of the Future?
Gail Dutton
Ann Intern Med. 1999;131(10):801-804. doi:10.7326/0003-4819-131-10-199911160-00101
Articles |  2 November 1999 FREE
The Cost-Effectiveness of Treating All Patients with Type 2 Diabetes with Angiotensin-Converting Enzyme Inhibitors
Lubor Golan, MD, MS; John D. Birkmeyer, MD; H. Gilbert Welch, MD, MPH
Ann Intern Med. 1999;131(9):660-667. doi:10.7326/0003-4819-131-9-199911020-00005
Articles |  19 October 1999
Cardiac and Arterial Target Organ Damage in Adults with Elevated Ambulatory and Normal Office Blood Pressure
Jennifer E. Liu, MD; Mary J. Roman, MD; Riccardo Pini, MD; et al.
Ann Intern Med. 1999;131(8):564-572. doi:10.7326/0003-4819-131-8-199910190-00003
Editorials |  19 October 1999
Integrating Routine Inquiry about Domestic Violence into Daily Practice
Carole Warshaw, MD; Elaine Alpert, MD
Ann Intern Med. 1999;131(8):619-620. doi:10.7326/0003-4819-131-8-199910190-00012
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)